EP4392052A4 - COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF LUNG DISEASE - Google Patents

COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF LUNG DISEASE

Info

Publication number
EP4392052A4
EP4392052A4 EP22862231.2A EP22862231A EP4392052A4 EP 4392052 A4 EP4392052 A4 EP 4392052A4 EP 22862231 A EP22862231 A EP 22862231A EP 4392052 A4 EP4392052 A4 EP 4392052A4
Authority
EP
European Patent Office
Prior art keywords
compositions
treating
methods
lung disease
preventing lung
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP22862231.2A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP4392052A1 (en
Inventor
Julie Ledford
Monica Kraft
Josef Vagner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Arizona
Original Assignee
University of Arizona
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US17/409,642 external-priority patent/US20210379141A1/en
Application filed by University of Arizona filed Critical University of Arizona
Priority claimed from PCT/US2022/075356 external-priority patent/WO2023028491A1/en
Publication of EP4392052A1 publication Critical patent/EP4392052A1/en
Publication of EP4392052A4 publication Critical patent/EP4392052A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP22862231.2A 2021-08-23 2022-08-23 COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF LUNG DISEASE Pending EP4392052A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17/409,642 US20210379141A1 (en) 2016-04-11 2021-08-23 Compositions and methods for treating and preventing lung disease
PCT/US2022/075356 WO2023028491A1 (en) 2021-08-23 2022-08-23 Compositions and methods for treating and preventing lung disease

Publications (2)

Publication Number Publication Date
EP4392052A1 EP4392052A1 (en) 2024-07-03
EP4392052A4 true EP4392052A4 (en) 2025-07-23

Family

ID=85278728

Family Applications (1)

Application Number Title Priority Date Filing Date
EP22862231.2A Pending EP4392052A4 (en) 2021-08-23 2022-08-23 COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF LUNG DISEASE

Country Status (6)

Country Link
EP (1) EP4392052A4 (https=)
JP (1) JP2024532412A (https=)
KR (1) KR20240052799A (https=)
CN (1) CN118076372A (https=)
AU (1) AU2022332283A1 (https=)
CA (1) CA3175945A1 (https=)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190117741A1 (en) * 2016-04-11 2019-04-25 Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for treating and preventing lung disease
WO2021207514A1 (en) * 2020-04-08 2021-10-14 Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for treating and preventing lung disease

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190117741A1 (en) * 2016-04-11 2019-04-25 Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for treating and preventing lung disease
WO2021207514A1 (en) * 2020-04-08 2021-10-14 Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for treating and preventing lung disease

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2023028491A1 *

Also Published As

Publication number Publication date
AU2022332283A1 (en) 2024-03-07
CA3175945A1 (en) 2023-02-23
EP4392052A1 (en) 2024-07-03
CN118076372A (zh) 2024-05-24
JP2024532412A (ja) 2024-09-05
KR20240052799A (ko) 2024-04-23

Similar Documents

Publication Publication Date Title
IL286350A (en) Preparations and methods for the treatment of cancer
IL288914A (en) Preparations and methods for the treatment of cancer
ZA202210078B (en) Compositions and methods for treating and preventing non-malignant respiratory disease
ZA202104870B (en) Methods and compositions for treating cancer
IL285886A (en) Preparations and methods for the treatment of laminopathy
IL304273A (en) Compositions and methods for treating Fabry disease
ZA202205289B (en) Compositions and methods for treating liver disease
IL285197A (en) Methods and preparations for the treatment of sleep apnea
SMT202500382T1 (it) Composizioni per trattare e/o prevenire malattie da aggregazione proteica
IL285796A (en) Methods and preparations for the treatment of cancer
IL287982A (en) Preparations and methods for the treatment of cancer
IL304771A (en) Preparations and methods for the treatment of a disease associated with dux4 overexpression
EP4341382A4 (en) COMPOSITIONS AND METHODS FOR TREATING DISEASES
ZA202107235B (en) Compositions and methods for treating ocular disease
IL286153A (en) Methods and preparations for the treatment of cancer
IL280868A (en) Preparations and methods for the treatment of acute lung injury
IL308530A (en) Preparations and methods for treating lung cancer
IL286083A (en) Compositions and methods for treating Huntington's disease
EP4392052A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF LUNG DISEASE
IL304675A (en) Preparations and methods for treating graft-versus-host disease
IL285036A (en) Methods and preparations for the treatment of cancer
EP4138862A4 (en) COMPOSITIONS AND METHODS FOR TREATING UPPER AIRWAY INFECTIONS
GB202313798D0 (en) Methods and compositions for treating or preventing a disease or a condition
HK40116997A (en) Compositions and methods for treating disease
AU2021903624A0 (en) Compositions and methods for treating disease

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20240325

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20250624

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 38/17 20060101AFI20250617BHEP

Ipc: A61K 9/00 20060101ALI20250617BHEP

Ipc: A61P 11/00 20060101ALI20250617BHEP

Ipc: C07K 7/06 20060101ALI20250617BHEP

Ipc: C07K 4/00 20060101ALI20250617BHEP

Ipc: C07K 7/00 20060101ALI20250617BHEP

Ipc: C07K 14/00 20060101ALI20250617BHEP